Jim Cramer: Valeant Is ‘Not So Hot’

TheStreet's Jim Cramer isn't too bullish on shares of Valeant Pharmaceuticals for a few reasons.
Author:
Publish date:

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't too bullish on shares of Valeant Pharmaceuticals (VRX) . 'I don't like companies that waive their debt agreements - I like companies that pay their debt,' Cramer said. 'Valeant - not so hot.' Valeant shares lost 73 percent since the start of the year.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.